Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

SHA:605199 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,845	6,374	6,066	6,410	9,971	9,651
Market Cap Growth	-59.74%	5.08%	-5.37%	-35.71%	3.32%	-
Enterprise Value	4,096	7,596	7,039	6,749	10,111	9,721
Last Close Price	7.11	15.93	14.97	15.82	24.60	23.69
PE Ratio	-	-	558.97	74.81	138.22	79.43
PS Ratio	2.67	4.51	3.38	4.23	7.37	8.31
PB Ratio	3.87	8.57	5.70	6.31	10.72	10.53
P/TBV Ratio	5.90	12.59	7.11	7.03	12.25	12.19
P/OCF Ratio	24.89	-	214.70	26.85	97.29	2924.53
EV/Sales Ratio	3.85	5.37	3.92	4.45	7.47	8.37
EV/EBITDA Ratio	-	-	94.98	46.94	86.08	67.48
EV/EBIT Ratio	-	-	323.73	69.20	139.08	96.68
Debt / Equity Ratio	1.79	1.88	1.21	0.67	0.54	0.31
Debt / EBITDA Ratio	-	-	15.90	4.60	4.13	1.96
Debt / FCF Ratio	44.97	-	-	-	-	-
Net Debt / Equity Ratio	1.64	1.54	0.71	0.20	0.01	-0.07
Net Debt / EBITDA Ratio	-23.01	-5.58	10.24	1.42	0.10	-0.44
Net Debt / FCF Ratio	41.19	-3.75	-1.65	-1.33	-0.33	1.12
Asset Turnover	0.36	0.48	0.68	0.74	0.83	0.89
Inventory Turnover	1.79	2.05	3.61	3.02	2.74	2.64
Quick Ratio	0.47	0.47	0.95	0.89	1.07	1.40
Current Ratio	0.82	0.85	1.27	1.18	1.37	1.76
Return on Equity (ROE)	-16.95%	-29.83%	1.63%	8.71%	7.53%	15.57%
Return on Assets (ROA)	-2.99%	-5.89%	0.52%	2.99%	2.77%	4.82%
Return on Invested Capital (ROIC)	-7.24%	-15.00%	0.90%	7.87%	6.90%	12.01%
Return on Capital Employed (ROCE)	-9.50%	-18.20%	1.20%	7.80%	7.50%	10.30%
Earnings Yield	-5.91%	-4.31%	0.18%	1.34%	0.72%	1.26%
FCF Yield	1.03%	-4.79%	-7.60%	-2.40%	-0.35%	-0.58%
Dividend Yield	-	-	0.83%	-	-	0.63%
Payout Ratio	-	-	290.87%	16.75%	102.23%	6.58%
Buyback Yield / Dilution	-3.98%	-9.97%	11.35%	-1.81%	-5.55%	-4.13%
Total Shareholder Return	-3.98%	-9.97%	12.18%	-1.81%	-5.55%	-3.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.